Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Research Report 2024(Status and Outlook)

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Research Report 2024(Status and Outlook)



Report Overview:

There are commercialvaccinesavailable containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. Thesevaccinesare licensed in both breeding or growingpigs.

The Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size was estimated at USD 389.82 million in 2023 and is projected to reach USD 698.16 million by 2029, exhibiting a CAGR of 10.20% during the forecast period.

This report provides a deep insight into the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market in any manner.

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

CAHIC

Boehringer Ingelheim

MSD Animal Health

Sino Pharm

Ceva

ChengDu Tecbond

Ringpu Biology

Qilu Animal

DHN

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Phibro Animal Health

Tecon

Zoetis

WINSUN

PULILE

Market Segmentation (by Type)

Live Vaccines

Killed Vaccines

Market Segmentation (by Application)

Government Tender

Market Sales

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market

Overview of the regional outlook of the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
1.2 Key Market Segments
1.2.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type
1.2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Landscape
3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Sites, Area Served, Product Type
3.6 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Situation and Trends
3.6.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Chain Analysis
4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2019-2024)
7 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Sales by Application (2019-2024)
7.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate by Application (2019-2024)
8 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segmentation by Region
8.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region
8.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region
8.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 CAHIC
9.1.1 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.1.2 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.1.4 CAHIC Business Overview
9.1.5 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
9.1.6 CAHIC Recent Developments
9.2 Boehringer Ingelheim
9.2.1 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.2.2 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.2.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.2.4 Boehringer Ingelheim Business Overview
9.2.5 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
9.2.6 Boehringer Ingelheim Recent Developments
9.3 MSD Animal Health
9.3.1 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.3.2 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
9.3.5 MSD Animal Health Business Overview
9.3.6 MSD Animal Health Recent Developments
9.4 Sino Pharm
9.4.1 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.4.2 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.4.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.4.4 Sino Pharm Business Overview
9.4.5 Sino Pharm Recent Developments
9.5 Ceva
9.5.1 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.5.2 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.5.4 Ceva Business Overview
9.5.5 Ceva Recent Developments
9.6 ChengDu Tecbond
9.6.1 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.6.2 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.6.4 ChengDu Tecbond Business Overview
9.6.5 ChengDu Tecbond Recent Developments
9.7 Ringpu Biology
9.7.1 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.7.2 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.7.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.7.4 Ringpu Biology Business Overview
9.7.5 Ringpu Biology Recent Developments
9.8 Qilu Animal
9.8.1 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.8.2 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.8.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.8.4 Qilu Animal Business Overview
9.8.5 Qilu Animal Recent Developments
9.9 DHN
9.9.1 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.9.2 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.9.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.9.4 DHN Business Overview
9.9.5 DHN Recent Developments
9.10 CAVAC
9.10.1 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.10.2 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.10.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.10.4 CAVAC Business Overview
9.10.5 CAVAC Recent Developments
9.11 Komipharm
9.11.1 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.11.2 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.11.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.11.4 Komipharm Business Overview
9.11.5 Komipharm Recent Developments
9.12 Agrovet
9.12.1 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.12.2 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.12.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.12.4 Agrovet Business Overview
9.12.5 Agrovet Recent Developments
9.13 Bioveta
9.13.1 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.13.2 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.13.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.13.4 Bioveta Business Overview
9.13.5 Bioveta Recent Developments
9.14 Jinyu Bio-Technology
9.14.1 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.14.2 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.14.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.14.4 Jinyu Bio-Technology Business Overview
9.14.5 Jinyu Bio-Technology Recent Developments
9.15 Phibro Animal Health
9.15.1 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.15.2 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.15.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.15.4 Phibro Animal Health Business Overview
9.15.5 Phibro Animal Health Recent Developments
9.16 Tecon
9.16.1 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.16.2 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.16.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.16.4 Tecon Business Overview
9.16.5 Tecon Recent Developments
9.17 Zoetis
9.17.1 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.17.2 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.17.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.17.4 Zoetis Business Overview
9.17.5 Zoetis Recent Developments
9.18 WINSUN
9.18.1 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.18.2 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.18.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.18.4 WINSUN Business Overview
9.18.5 WINSUN Recent Developments
9.19 PULILE
9.19.1 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Basic Information
9.19.2 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
9.19.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Market Performance
9.19.4 PULILE Business Overview
9.19.5 PULILE Recent Developments
10 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Forecast by Region
10.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast
10.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Region
10.2.4 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Type (2025-2030)
11.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Type (2025-2030)
11.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings